Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Match between Molecular Subtypes, Histology and Microenvironment of Pancreatic Cancer and Its Relevance for Chemoresistance
Javier Martínez‐Useros, Mario Martin-Galan, Jesús García‐Foncillas
Cancers (2021) Vol. 13, Iss. 2, pp. 322-322
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer
Amina Jbara, Kuan‐Ting Lin, Chani Stossel, et al.
Nature (2023) Vol. 617, Iss. 7959, pp. 147-153
Open Access | Times Cited: 65
PDAC, the Influencer Cancer: Cross-Talk with Tumor Microenvironment and Connected Potential Therapy Strategies
Leonardo Mercanti, Maria Sindaco, Mariangela Mazzone, et al.
Cancers (2023) Vol. 15, Iss. 11, pp. 2923-2923
Open Access | Times Cited: 26
Trends in the Global Incidence of Pancreatic Cancer and a Brief Review of its Histologic and Molecular Subtypes
Premila D. Leiphrakpam, Sanjib Chowdhury, Michelle Zhang, et al.
Journal of Gastrointestinal Cancer (2025) Vol. 56, Iss. 1
Closed Access | Times Cited: 1
Activated Regulatory T-Cells, Dysfunctional and Senescent T-Cells Hinder the Immunity in Pancreatic Cancer
Shivan Sivakumar, Enas Abu‐Shah, David Ahern, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1776-1776
Open Access | Times Cited: 43
Cholesterol metabolism in pancreatic cancer and associated therapeutic strategies
Tasvi Daya, Andrea Breytenbach, Liang Gu, et al.
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2024) Vol. 1870, Iss. 2, pp. 159578-159578
Open Access | Times Cited: 5
Deletion of the mRNA stability factor ELAVL1 (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity
Grace A. McCarthy, Roberto Di Niro, Jennifer M. Finan, et al.
NAR Cancer (2023) Vol. 5, Iss. 2
Open Access | Times Cited: 12
Spatial recognition and semi-quantification of epigenetic events in pancreatic cancer subtypes with multiplexed molecular imaging and machine learning
K Szymoński, Natalia Janiszewska, Kamila Sofińska, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
A Novel PiRNA Enhances CA19-9 Sensitivity for Pancreatic Cancer Identification by Liquid Biopsy
Weiyao Li, Miguel Gonzalez-Gonzalez, Lara Sanz-Criado, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 24, pp. 7310-7310
Open Access | Times Cited: 16
Integrating Network Pharmacology and Experimental Verification to Explore the Mechanism of Effect of Zuojin Pills in Pancreatic Cancer Treatment
Kunpeng Wang, Xiongying Miao, Fanhua Kong, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 3749-3764
Open Access | Times Cited: 19
Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
Rita Rebelo, Bárbara Polónia, Lúcio Lara Santos, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 280-280
Open Access | Times Cited: 18
Targeting the Stroma in the Management of Pancreatic Cancer
Penelope Edwards, Byung Woog Kang, Ian Chau
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 17
Current Pathology Model of Pancreatic Cancer
K Szymoński, Katarzyna Milian-Ciesielska, Ewelina Lipiec, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2321-2321
Open Access | Times Cited: 12
Glutathione Peroxidases: An Emerging and Promising Therapeutic Target for Pancreatic Cancer Treatment
Paula Iglesias-Matesanz, Carlos Lacalle-Gonzalez, Carlos Lopez-Blazquez, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1405-1405
Open Access | Times Cited: 2
Iron-Dependent Cell Death: A New Treatment Approach against Pancreatic Ductal Adenocarcinoma
Carlos Lopez-Blazquez, Carlos Lacalle-Gonzalez, Lara Sanz-Criado, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 14979-14979
Open Access | Times Cited: 5
Nuclear Dynamics and Chromatin Structure: Implications for Pancreatic Cancer
Luis F. Flores, Brooke R. Tader, Ezequiel J. Tolosa, et al.
Cells (2021) Vol. 10, Iss. 10, pp. 2624-2624
Open Access | Times Cited: 12
Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case Report
Clelia Madeddu, E. Sanna, Sonia Nemolato, et al.
Diagnostics (2022) Vol. 12, Iss. 8, pp. 1910-1910
Open Access | Times Cited: 8
Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma
Emmanuel Salinas-Miranda, Gerard M. Healy, Barbara T. Grünwald, et al.
European Radiology (2022) Vol. 32, Iss. 10, pp. 6712-6722
Closed Access | Times Cited: 8
Identification of Novel Metabolism-Associated Subtypes for Pancreatic Cancer to Establish an Eighteen-Gene Risk Prediction Model
Yang Gao, Enchong Zhang, Fei Xiang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 10
Pancreatic ductal adenocarcinoma microenvironment: Soluble factors and cancer associated fibroblasts as modulators of NK cell functions
Simona Carlomagno, Chiara Setti, Fulvia Ortolani, et al.
Immunology Letters (2024) Vol. 269, pp. 106898-106898
Open Access | Times Cited: 1
HROP68: A rare case of medullary pancreatic cancer—characterization and chemosensitivity of the first patient-derived cell line
Jens von den Driesch, Jana Flöttmann, Friedrich Prall, et al.
Frontiers in Oncology (2023) Vol. 12
Open Access | Times Cited: 3
Expression of lactate-related signatures correlates with immunosuppressive microenvironment and prognostic prediction in ewing sarcoma
Zhao Zhang, Jingxin Pan, Debin Cheng, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 5
Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine
Ryan N. Fuller, Janviere Kabagwira, Paul Vallejos, et al.
OncoTargets and Therapy (2022) Vol. Volume 15, pp. 1147-1160
Open Access | Times Cited: 5
Application of Mass Spectrometry in Pancreatic Cancer Translational Research
Peng Ge, Yalan Luo, Haiyang Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 6
Multiplexed molecular imaging identifies pancreatic cancer candidates for epigenetic modulators
K Szymoński, Natalia Janiszewska, Kamila Sofińska, et al.
Research Square (Research Square) (2024)
Closed Access
Unbiased Quantitative Proteomics of Organoid Models of Pancreatic Cancer
Ronnie Ren Jie Low, Ka Yee Fung, Laura F. Dagley, et al.
Methods in molecular biology (2024), pp. 77-93
Closed Access
Page 1 - Next Page

Scroll to top